Irene Velasco

ORCID: 0000-0001-5497-5813 · 30 papers in corpus
observational 2025
The Science of the total environment ·doi:10.1016/j.scitotenv.2025.180270

BACKGROUND: Endometriosis disease affects up to 10 % of menstruating people worldwide and can lead to infertility. Environmental pollutants are risk factors influencing the probability of developing endometriosis. OBJECTIVE: We aimed to ex…

2024
·doi:10.1016/j.fertnstert.2024.07.567
other 2023
Toxics ·doi:10.3390/toxics11050399

Toxic metals found in the environment have been linked to female infertility and gynecological illnesses. Reliable analytical methods, such as inductively coupled plasma tandem mass spectrometry (ICP-MS/MS), are necessary to determine the e…

case-report 2023
Toxics ·doi:10.3390/toxics11121009

Potentially toxic elements (PTEs), found as environmental contaminants, have been related to endometriosis disease. In this context, the peritoneal fluid (PF) matrix has been poorly studied despite its importance. PF is the environment in w…

rct 2021
BMC women's health ·doi:10.1186/s12905-021-01347-9

BACKGROUND: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated with levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. METHODS: Prospective, randomized clinical tri…

observational 2021
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14679

AIM: To evaluate if the long-term results (on fertility, need of hysterectomy and persistence of endometriosis) after a minimally invasive intervention (transvaginal ultrasound-guided puncture-aspiration [TUGPA]) for endometriomas are signi…

rct 2020
·doi:10.21203/rs.3.rs-51837/v4

Abstract Background: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated to levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis.Methods: Prospective, randomized clinic…

rct 2020
·doi:10.21203/rs.3.rs-51837/v2

Abstract Background: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated to levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. Methods: Prospective, randomized clinic…

2020
·doi:10.21203/rs.3.rs-51837/v1
rct 2020
·doi:10.21203/rs.3.rs-51837/v3

Abstract Background: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated to levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. Methods: Prospective, randomized clinic…

rct 2019
·doi:10.20944/preprints201911.0010.v1

Background: Effectiveness of Anastrozole and levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. Methods: Randomized clinical trial. Elegibility criteria: Endometriomas >3×4 cm, CA…

other 2019
Reproductive biology ·doi:10.1016/j.repbio.2019.12.001

The success of mammalian fertilization depends largely on spermatozoa physiological events. However, the manner in which endometriosis influence morpho-functional spermatozoa biomarkers is poorly defined. Here, we studied in vitro the effec…

review 2016

Copyright © 2013 P. Acién and I. Velasco. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work i…

2016

International Journal of Women’s Health Is a bowel resection necessary for deep endometriosis with rectovaginal or colorectal involvement?

observational 2015
Gynecologic and obstetric investigation ·doi:10.1159/000367597

AIMS: To determine the prevalence of endometriosis in epithelial ovarian cancers (EOC) and the association among their histological subtypes and with endometrial carcinoma. METHODS: An observational cohort study performed in 192 patients o…

review 2013
ISRN obstetrics and gynecology ·doi:10.1155/2013/242149

Endometriosis, a gynecologic pathology, is defined by the presence of a tissue similar to uterine endometrium, which is located in places other than physiologically appropriate. These endometrial heterotopic islets contain glands and stroma…

observational 2013
International journal of women's health ·doi:10.2147/ijwh.s46519

BACKGROUND: The purpose of this paper is to report the long-term results of surgery without bowel resection in patients suffering from deep infiltrating endometriosis with rectovaginal or colorectal involvement. METHODS: This retrospective…

observational 2010
Journal of Reproductive Immunology ·doi:10.1016/j.jri.2009.11.004

Immunological changes and gene expression anomalies are involved in the etiopathophysiology of endometriosis, although how these alterations are connected is not well established. The aim of this study was to determine the relationship betw…

rct 2009
Gynecologic and obstetric investigation ·doi:10.1159/000270901

BACKGROUND: To analyze the therapeutic results of recombinant interleukin-2 (rIL-2) left in the cysts after transvaginal ultrasound (US)-guided drainage of endometriomas as an alternative to surgery. METHODS: Prospective and randomized cli…

observational 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.11.188

OBJECTIVE: To study the relationship between aromatase expression in endometriotic tissues and clinical and laboratory findings. DESIGN: Prospective basic and clinical research. SETTING: University hospital. PATIENT(S): Sixty-two women w…

2007

La presente tesis doctoral, estructurada en capitulos, es una investigacion original que tiene como objetivo fundamental profundizar en la inmunologia de la endometriosis e intentar apuntar hacia nuevas acciones terapeuticas para hacer fren…

other 2007
Journal of Reproductive Immunology ·doi:10.1016/j.jri.2006.12.001

The aim of this double-blinded study was to determine changes in leukocyte populations in blood, peritoneal lavage fluid, eutopic and ectopic endometrium after treatment with recombinant rat interleukin-2 (IL-2) using an in vivo experimenta…

other 2007
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2006.11.021

OBJECTIVE: To evaluate the effect of interleukin-2 (IL-2) on an experimental model of endometriosis. STUDY DESIGN: Double blind and randomized experimental prospective placebo-controlled study. Experimental endometriosis was induced in 66 …

other 2006
Molecular human reproduction ·doi:10.1093/molehr/gal041

Cytochrome P-450 aromatase is responsible for catalysing the conversion of androstendione into estrone, so its expression in endometriotic tissue could contribute to the development of endometriosis. The aims of this study were, on the one …

rct 2005
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.10.035

OBJECTIVE: To determine the changes in cytokine levels from women with endometriomas who are treated with recombinant interleukin-2 after ultrasound-guided cyst aspiration, and to relate these changes to the clinical results observed in the…